| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| Risperidone impurity 6/Risperidone EP Impurity H/Risperidone difluoroketone/3-[2-[4-(2,4-Difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
利培酮雜質(zhì)H |
158697-67-7 |
詳細(xì)
|
| Trazodone impurity 2/Trazodone 4-Chloro Analog/2-{3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one |
4-Chloro Trazodone |
157072-19-0 |
詳細(xì)
|
| Risperidone impurity 9/Risperidone EP Impurity K/Desfluoro Risperidone/3-[2-[4-(1,2-Benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one |
利培酮雜質(zhì)K |
106266-09-5 |
詳細(xì)
|
| Omeprazole impurity 12/Omeprazole N-Methyl 6-Methoxy Analog/6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole |
埃索美拉唑進(jìn)口標(biāo)準(zhǔn)雜質(zhì)H193/61 |
784143-42-6 |
詳細(xì)
|
| Indomethacin impurity 2/Indomethacin EP Impurity C/4-Chloro-N-(4-methoxyphenyl)-benzamide |
4-氯-N-(4-甲氧基苯基)苯甲酰胺 |
4018-82-0 |
詳細(xì)
|
| Nateglinide impurity 1/Nateglinide Methyl Ester/methyl (2S)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoate |
那格列奈甲酯 |
105746-47-2 |
詳細(xì)
|
| Esomeprazole impurity 5/4sodium 2-(((3,5-dimethyl-4-oxidopyridin-2-yl)methyl)sulfinyl)-5-methoxybenzo[d]imidazol-1-ide |
2-(((3,5-二甲基-4-氧化吡啶-2-基)甲基)亞磺酰基)-5-甲氧基苯并[d]咪唑-1-鈉 |
1803449-15-1 |
詳細(xì)
|
| Racecadotril impurity 1/Racecadotril EP impurity B/Thiorphan/[[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetic acid |
3-巰基-2芐基丙基甘氨酸 |
76721-89-6 |
詳細(xì)
|
| Gefitinib impurity 6/O-Desmethyl Gefitinib/4-((3-chloro-4-fluorophenyl)amino)-6-(3-morpholinopropoxy)quinazolin-7-ol |
O-去甲基吉非替尼 |
847949-49-9 |
詳細(xì)
|
| Umeclidinium bromide impurity 1/1-Azabicyclo[2.2.2]octane-4-carboxylic acid |
1-氮雜雙環(huán)[2,2,2]辛烷-4-羧酸 |
55022-88-3 |
詳細(xì)
|
| Solifenacin impurity 5/Solifenacin EP Impurity I/Solifenacin N-Oxide/(1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid (3R)-1-Oxido-1 -azabicyclo[2.2.2]oct-3-yl Ester |
索利那新N-氧化物 |
180272-28-0 |
詳細(xì)
|
| Gefitinib impurity 15/4-Defluoro-4-Hydroxy Gefitinib/2-chloro-4-((7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)amino)phenol |
4-脫氟-4-羥基吉非替尼 |
847949-50-2 |
詳細(xì)
|
| Risperidone impurity 7/Risperidone EP Impurity I/ 3-[2-[4-[4-Fluoro-2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]benzoyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H- pyrido[1,2-a]pyrimidin-4-one |
利培酮雜質(zhì)I |
1329796-66-8 |
詳細(xì)
|
| Nateglinide impurity 5/Nateglinide EP Impurity G/Nateglinide Ethyl Ester/(R)-ethyl 2-((1s,4S)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoate; ethyl N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalaninate |
那格列奈乙酯 |
187728-85-4 |
詳細(xì)
|
| NateglinideEPImpurityF |
那格列奈雜質(zhì) |
944746-48-9 |
詳細(xì)
|
| Montelukast impurity 11/Montelukast EP Impurity H/Montelukast Methoxycarbonyl Analog/2-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(methoxycarbonyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetic acid |
孟魯斯特雜質(zhì)H |
851755-56-1 |
詳細(xì)
|
| Clozapine impurity 4/Clozapine EP Impurity D/Clozapine impurity B (USP)/(2-((2-amino-4-chlorophenyl)amino)phenyl)(4-methylpiperazin-1-yl)methanone |
氯氮平雜質(zhì)D |
65514-71-8 |
詳細(xì)
|
| Regorafenib impurity 3/Regorafenib Urea Impurity/1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea |
瑞戈非尼雜質(zhì) |
1333390-56-9 |
詳細(xì)
|
| Itopride impurity 4/3,4-Dimethoxy-N-[4-(2-methylamino-ethoxy)-benzyl]benzamide |
伊托必利雜質(zhì)2 |
141996-97-6 |
詳細(xì)
|
| Solifenacin impurity 3/Solifenacin EP Impurity C/Solifenacin (S,S) Methanone Impurity/Bis[(1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinyl]-methanone |
索利那新雜質(zhì) B |
1534326-81-2 |
詳細(xì)
|
| Apixaban impurity 17/Methyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
阿哌沙班雜質(zhì)15 |
1466571-07-2 |
詳細(xì)
|
| Apixaban impurity 5/1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo\[3,4-c]pyridine-3-carboxamide |
阿哌沙班雜質(zhì)5 |
2029205-64-7 |
詳細(xì)
|
| Umeclidinium bromide impurity 3/1-[2-(Benzoyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-azoniabicyclo[2.2.2]octane bromide |
蕪地溴銨雜質(zhì)3 |
869113-45-1 |
詳細(xì)
|
| Omeprazole impurity 2/Omeprazole Pyridone Acid Ammonium Salt/1,4-Dihydro-1-(5-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic Acid Ammonium Salt |
埃索美拉唑雜質(zhì)H431 |
2227107-89-1 |
詳細(xì)
|
| Lansoprazole impurity 2/Lansoprazole EP Impurity B/Lansoprazole Sulfone/2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulfonyl]-1H-benzimidazole |
蘭索拉唑磺酸鹽 |
131926-99-3 |
詳細(xì)
|
| Gefitinib impurity 7/3-Desmorpholinyl-3-hydroxyethylamino Gefitinib/2-((3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)amino)ethan-1-ol |
吉非替尼雜質(zhì) |
847949-56-8 |
詳細(xì)
|
| Irbesartan impurity 2/Demethyl Irbesartan/Irbesartan Propyl Analog/2-Propyl-3-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one |
厄貝沙坦雜質(zhì) |
158778-58-6 |
詳細(xì)
|
| Umeclidinium bromide impurity 4/4-(Hydroxydiphenylmethyl)-1-(2-hydroxyethyl)-1-azoniabicyclo[2.2.2]octane bromide |
蕪地溴銨雜質(zhì)4 |
869112-31-2 |
詳細(xì)
|
| Solifenacin impurity 4/Solifenacin EP Impurity D/Solifenacin (R,S) Methanone Impurity/[(1R)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl][(1S)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl]methanone |
索利那新-索非那新雜質(zhì) |
2216750-52-4 |
詳細(xì)
|
| Lansoprazole impurity 12/(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl Acetate |
2-乙酰氧甲基-3-甲基-4-(三氟乙氧基)吡啶 |
112525-75-4 |
詳細(xì)
|
| Omeprazole impurity 8/Omeprazole EP Impurity H/(S)-4-Desmethoxy-4-chloro Omeprazole/2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole |
（S）-4-去甲氧基-4-氯奧美拉唑 |
863029-89-4 |
詳細(xì)
|
| Omeprazole impurity 13/4-Desmethoxy-4-nitro Omeprazole/4-Desmethoxy-4-nitro Omeprazole/2-[[(3,5-Dimethyl-4-nitro-2-pyridinyl) methyl]sulfinyl]-5-methoxy-1H-benzimidazole |
rac 4-去甲氧基-4-硝基奧美拉唑 |
317807-10-6 |
詳細(xì)
|
| Itopride impurity 5/Itopride N-Oxide/2-(4-((3,4-dimethoxybenzamido)methyl)phenoxy)-N,N-dimethylethan-1-amine oxide |
伊托比利N氧化物 |
141996-98-7 |
詳細(xì)
|
| Esomeprazole impurity 8/2-Chloromethyl-4-methoxy-3,5-dimethylpyridine 1-Oxide |
2-氯甲基-3,5-二甲基-4-甲氧基吡啶氮氧化物 |
848694-10-0 |
詳細(xì)
|
| Lansoprazole impurity 6/N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl Lansoprazole Sulfide/1-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzimidazole |
N-[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基蘭索拉唑硫醚 |
1083100-27-9 |
詳細(xì)
|
| Solifenacin impurity 10/Solifenacin R Isomer/(R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
(R)-1-苯基-1,2,3,4-四氫異喹啉 |
180272-45-1 |
詳細(xì)
|
| Lansoprazole impurity 20/Lansoprazole Sulfide N-Oxide/Lansoprazole Pyridine N-Oxide/2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzimidazole N-Oxide |
蘭索拉唑硫醚-N-氧化物 |
163119-30-0 |
詳細(xì)
|
| Risperidone impurity 2/Risperidone EP Impurity B/Risperidone Z-Oxime/3-[2-[4-[(Z)-(2,4-Difluorophenyl)(hydroxyimino) methyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
利培酮雜質(zhì)B |
132961-05-8 |
詳細(xì)
|
| Risperidone impurity 10/Risperidone Metabolite/Risperidone 2-Hydroxybenzoyl Impurity/3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
利培酮2-乙氨基雜質(zhì) |
152542-00-2 |
詳細(xì)
|
| Apixaban impurity 1/1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
阿哌沙班雜質(zhì) |
1074365-84-6 |
詳細(xì)
|
| Indomethacin impurity 5/Indomethacin EP Impurity F/2-(4-Chlorobenzoyl)-1-(4-methoxyphenyl)hydrazide-4-chloro-benzoic acid |
吲哚美辛雜質(zhì)14 |
402849-27-8 |
詳細(xì)
|
| Regorafenib impurity 5/
Regorafenib (Pyridine)-N-oxide/4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide |
瑞戈非尼雜質(zhì) |
835621-11-9 |
詳細(xì)
|
| Loxoprofen impurity 1/2-(4-(hydroxymethyl)phenyl)propanoic acid |
2- [對(duì)-（羥甲基）苯基]丙酸 |
88416-60-8 |
詳細(xì)
|
| Lansoprazole impurity 3/Lansoprazole EP Impurity C/Lansoprazole Sulfide/2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole |
蘭索拉唑硫醚 |
103577-40-8 |
詳細(xì)
|
| Lacosamide impurity 8/Lacosamide EP Impurity H/(S)-2-acetamido-N-((S)-1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)-3-methoxypropanamide |
拉考沙胺雜質(zhì)H |
1375090-19-9 |
詳細(xì)
|
| Lansoprazole impurity 7/Lansoprazole Sulfone N-Oxide/2-(((1H-benzo[d]imidazol-2-yl)sulfonyl)methyl)-3-methyl-4-(2,2,2- trifluoroethoxy)pyridine 1-oxide |
蘭索拉唑楓氮氧化物 |
953787-54-7 |
詳細(xì)
|
| Trazodone impurity 6/Trazodone N-Oxide/2-[3-[4-(3-Chlorophenyl)-1-oxido-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one |
曲唑酮雜質(zhì)A |
55290-68-1 |
詳細(xì)
|
| Irbesartan impurity 1/Irbesartan Cyano Impurity/4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]biphenyl-2-carbonitrile |
厄貝沙坦雜質(zhì) |
138401-24-8 |
詳細(xì)
|
| Solifenacin impurity 9/(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarbonyl Chloride |
(S)-1-苯基-1,2,3,4-四氫-1H-異喹啉-2-甲酰氯 |
1195949-26-8 |
詳細(xì)
|
| Loxoprofen impurity 6/2-[(4-Acetylphenyl)methyl]cyclopentan-1-one |
洛索洛芬雜質(zhì)1 |
96824-28-1 |
詳細(xì)
|
| Solifenacin impurity 2/Solifenacin EP Impurity B/(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid 1-Methylethyl Ester |
索利那新雜質(zhì) 1 |
1353274-25-5 |
詳細(xì)
|
| Itopride impurity 1/4-[2-(Dimethylamino)ethoxy]benzylamine |
4-[2-(二甲基氨基)乙氧基]芐胺 |
20059-73-8 |
詳細(xì)
|
| Clozapine impurity 5/Clozapine N-Oxide/4-(8-chloro-5H-dibenzo[b,e][1,4]diazepin-11-yl)-1-methylpiperazine 1-oxide |
氯氮平-N-氧化物 |
34233-69-7 |
詳細(xì)
|
| Omeprazole impurity 16/Omeprazole Hydroxymethyl HCl/(4-Methoxy-3,5-dimethylpyridin-2-yl)methanol Hydrochloride |
(4-甲氧基-3,5-二甲基吡啶-2-基)甲醇鹽酸鹽 |
96300-88-8 |
詳細(xì)
|
| Ketoprofen impurity 1/Ketoprofen EP Impurity A/1-(3-benzoylphenyl)ethan-1-one |
3-乙酰苯甲酮 |
66067-44-5 |
詳細(xì)
|
| Omeprazole impurity 14/4-Desmethoxy Omeprazole Sulfide/2-(((3,5-dimethylpyridin-2-yl)methyl)thio)-6-methoxy-1H-benzo[d]imidazole |
2-[[(3,5-二甲基-2-吡啶基)甲基]硫基]-5-甲氧基-1H-苯并咪唑 |
704910-89-4 |
詳細(xì)
|
| Irbesartan impurity 3/N-((2’-cyanobiphenyl-4-yl)methyl)-1-pentanamido cyclopentane carboxamide |
厄貝沙坦雜質(zhì) |
141745-71-3 |
詳細(xì)
|
| Lacosamide impurity 5/Lacosamide EP Impurity E/Desacetyl Desmethyl Lacosamide/(2R)-2-Amino-3-hydroxy-N-(phenylmethyl)-propanamide |
拉科酰胺雜質(zhì) |
175481-39-7 |
詳細(xì)
|
| Cimetidine impurity 8/Cimetidine EP Impurity H/1,1′-(Disulfanediyldiethylene)bis(2-cyano-3-methylguanidine) |
N-氰基-3-(氰基氨基)-N'-甲基-7,8-二硫雜-2,4,11-三氮雜十二碳-2-烯-12-甲脒 |
74886-59-2 |
詳細(xì)
|
| Lacosamide impurity 10/Lacosamide EP Impurity K/2-acetamido-N-benzylacrylamide |
乳糖酰胺雜質(zhì)A |
86921-49-5 |
詳細(xì)
|
| Cimetidine impurity 6/Cimetidine EP Impurity F/Cimetidine bis Impurity/2-Cyano-1,3-bis[2-[[(5-methyl-1H-imidazol-4-yl)methyl]-sulfanyl]ethyl] guanidine |
西咪替丁EP雜質(zhì)F |
55272-86-1 |
詳細(xì)
|
| Indomethacin impurity 1/5-methoxy-2-methyl-1H-Indole-3-acetic acid |
5-甲氧基-2-甲基-3-吲哚乙酸 |
2882-15-7 |
詳細(xì)
|
| Risperidone impurity 1/Risperidone EP Impurity A/Risperidone E-Oxime/3-[2-[4-[(E)-(2,4-difluorophenyl)(hydroxyimino)methyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
利培酮 E-肟 |
691007-09-7 |
詳細(xì)
|
| Risperidone impurity 11/Risperidone N-Oxide/3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-oxido-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
3-[2-[4-(6-氟-1,2-苯并異惡唑-3-基)-1-氧代-1-哌啶基]乙基]-6,7,8,9-四氫-2-甲基-4H-吡啶并[1,2-A]嘧啶-4-酮 |
832747-55-4 |
詳細(xì)
|
| Lansoprazole impurity 1/Lansoprazole EP Impurity A /Lansoprazole N-Oxide/2-[[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole |
2-[[[3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶]甲基]亞硫?；鵠苯并咪唑 |
213476-12-1 |
詳細(xì)
|
| Cimetidine impurity 2/Cimetidine EP Impurity B/Cimetidine Methoxy Analog/Methyl 3-cyano-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl]ethyl]-carbamimidate |
N-氰基-N'-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫基]乙基]亞胺代氨基甲酸甲酯 |
138035-55-9 |
詳細(xì)
|
| Risperidone impurity 5/Risperidone EP Impurity F/Risperidone Carboxylate Impurity/2-[2-Methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a] pyrimidin-3-yl] ethyl 4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-carboxylate |
利培酮EP雜質(zhì)F |
1346603-86-8 |
詳細(xì)
|
| Apixaban impurity 12/Apixaban Amino Acid Impurity/5-((4-(3-carbamoyl-1-(4-methoxyphenyl)-7-oxo-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)phenyl)amino)pentanoic acid |
阿哌沙班氨基酸雜質(zhì) |
2206825-87-6 |
詳細(xì)
|
| 2-(1,6-dimethylpiperidin-3-yl)propan-2-ol |
|
91342-95-9 |
詳細(xì)
|
| Loxoprofen impurity 11/2-(4-((1-(Methoxycarbonyl)-2-oxocyclopentyl)methyl)phenyl)propanoic Acid |
洛索洛芬雜質(zhì)80 |
1027957-36-3 |
詳細(xì)
|
| Lansoprazole impurity 11/2,3-dimethyl-4-(2,2,2-trifluoroethoxy)pyridine 1-oxide |
2,3-二甲基-4-(2,2,2-三氟乙基)吡啶-N-氧化物 |
103577-61-3 |
詳細(xì)
|
| Omeprazole impurity 19/4-Desmethoxy-4-chloro Omeprazole Sulfide/2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]thio]-6-methoxy-1H-benzimidazole |
2-[[(4-氯-3,5-二甲基-2-吡啶基)甲基]硫基]-5-甲氧基苯并咪唑 |
220757-74-4 |
詳細(xì)
|
| Lansoprazole impurity 17/Lansoprazole R-Isomer/(R)-Lansoprazole/Dexlansoprazole/2-[(R)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole |
右旋蘭索拉唑 |
138530-94-6 |
詳細(xì)
|
| Solifenacin impurity 8/Solifenacin Ethyl Ester Impurity/(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic acid ethyl ester |
(S)-1-苯基-1,2,3,4-四氫-2-異喹啉甲酸乙酯 |
180468-42-2 |
詳細(xì)
|
| Trazodone impurity 1/Deschloro Trazodone/2-[3-(4-Phenyl-1-piperazinyl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one |
曲唑酮USP雜質(zhì)B |
62337-66-0 |
詳細(xì)
|
| Risperidone impurity 3/Risperidone EP Impurity D/Risperidone 5-Fluoro Isomer/3-[2-[4-(5-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
利培酮雜質(zhì)D |
1199589-74-6 |
詳細(xì)
|
| Indomethacin impurity 8/Indomethacin EP impurity I/ethyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate |
吲哚美辛EP雜質(zhì)I |
16401-99-3 |
詳細(xì)
|
| Fasudil impurity 8/Fasudil N-Hydroxy HCl Impurity/5-[(Hexahydro-4-hydroxy-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline hydrochloride |
N-羥基法舒地爾雜質(zhì) |
1350827-92-7 |
詳細(xì)
|
| Indomethacin impurity 4/Indomethacin EP impurity E/2-(1-(3-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid |
吲哚美辛EP雜質(zhì)E |
807614-94-4 |
詳細(xì)
|
| Trazodone impurity 4/4-Ethyl Trazodone/2-[3-[4-(3-Chloro-4-ethylphenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one |
鹽酸曲唑酮雜質(zhì) |
1346599-35-6 |
詳細(xì)
|
| Atorvastatin impurity 36/Atorvastatin 3-Deoxy-Hept-2-Enoic Acid Ethyl Ester/2,3-Anhydro Atorvastatin Acid Ethyl Ester/(5S)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-2-heptenoic acid ethyl ester |
阿托伐他汀雜質(zhì)36 |
1624328-52-4 |
詳細(xì)
|
| Fasudil impurity 12/5-(1,4-diazepan-1-ylsulfonyl)-2H-isoquinolin-1-one hydrochloride |
羥基法舒地爾 |
105628-72-6 |
詳細(xì)
|
| Clozapine impurity 3/Clozapine EP Impurity C/Clozapine impurity A (USP)/8-chloro-11-(piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine |
8-氯-11-(1-哌嗪基)-5H-二苯并[B,E] [1,4]吡喃 |
6104-71-8 |
詳細(xì)
|
| Lacosamide impurity 1/Lacosamide EP Impurity A/(S)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide |
拉科酰胺雜質(zhì) |
175481-37-5 |
詳細(xì)
|
| Lansoprazole impurity 15/Des(trifluoroethyl) Lansoprazole Sulfide/2-[(1H-Benzimidazol-2-ylthio)methyl]-3-methyl-4-pyridinol |
蘭索拉唑硫化物雜質(zhì) |
131926-97-1 |
詳細(xì)
|
| Omeprazole impurity 10/4-Hydroxy Omeprazole Sulfide/Omeprazole Pyridone/2-[[(6-Methoxy-1H-benzimidazol-2-yl)thio]methyl]-3,5-dimethyl-4-pyridinol |
埃索美拉唑有關(guān)物質(zhì) |
103876-98-8 |
詳細(xì)
|
| Risperidone impurity 8/Risperidone EP Impurity J/3-[2-[4-[(Z)-(4-Fluoro-2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)phenyl](hydroxyimino)methyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
利培酮雜質(zhì)J |
1346606-24-3 |
詳細(xì)
|
| Esomeprazole impurity 3/4-Methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide |
奧美拉唑雜質(zhì) |
142885-92-5 |
詳細(xì)
|
| Lacosamide impurity 2/Lacosamide EP Impurity B/Lacosamide O-Acetyl Impurity/(2R)-2-(Acetylamino)-3-(acetyloxy)-N-(phenylmethyl)-propanamide |
(R)-O-乙?；?拉克酰胺 |
1318777-54-6 |
詳細(xì)
|
| Apixaban impurity 15/6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
阿哌沙班雜質(zhì) 17 |
1423803-24-0 |
詳細(xì)
|
| Esomeprazole impurity 9/
Des-ethylsulfinyl-methoxybenzoimidazole 2-Acetyloxy Esomeprazole |
2-(乙酰氧基甲基)-4-甲氧基-3,5-二甲基吡啶 |
91219-90-8 |
詳細(xì)
|
| Loxoprofen impurity 7/2-(4-(2-oxo cyclopentylmethyl)phenyl)propionic acidmethyl ester |
洛索洛芬雜質(zhì)11 |
81762-92-7 |
詳細(xì)
|
| Indomethacin impurity 7/Indomethacin EP Impurity H/methyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate |
1-(4-氯苯甲?；?-5-甲氧基-2-甲基-1H-吲哚-3-乙酸甲酯 |
1601-18-9 |
詳細(xì)
|
| (15R)-Bimatoprost Acid/(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic Acid |
貝美前列素雜質(zhì) |
41639-71-8 |
詳細(xì)
|
| Lacosamide impurity 6/Lacosamide EP Impurity F/(2R)-2-(Acetylamino)-3-hydroxy-N-(phenylmethyl)propanamide |
去甲拉考沙胺 |
175481-38-6 |
詳細(xì)
|
| Repaglinide impurity 1/Repaglinide EP Impurity A/4-Carboxy-3-ethoxybenzeneacetic acid |
(4-羧基-3-乙氧基)苯乙酸 |
220438-80-2 |
詳細(xì)
|
| Risperidone impurity 4/Risperidone EP Impurity E/6-Methyl Risperidone/2,6-Dimethyl Risperidone/(6RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2,6-dimethyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
利培酮雜質(zhì)E |
1346602-28-5 |
詳細(xì)
|
| Racecadotril impurity 5/Racecadotril EP Imurity G/benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate |
消旋卡多曲雜質(zhì)G |
81110-69-2 |
詳細(xì)
|
| Indomethacin impurity 6/Indomethacin impurity G/2-(1-(3,4-dichlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid |
吲哚美辛EP雜質(zhì)G |
402849-26-7 |
詳細(xì)
|
| Trazodone impurity 3/Trazodone Bromo Analog/2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one |
Trazodone impurity 3/Trazodone Bromo Analog/2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one |
1263358-13-9 |
詳細(xì)
|